Correlation Between Spero Therapeutics and Scpharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Scpharmaceuticals.

Diversification Opportunities for Spero Therapeutics and Scpharmaceuticals

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Spero and Scpharmaceuticals is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Scpharmaceuticals go up and down completely randomly.

Pair Corralation between Spero Therapeutics and Scpharmaceuticals

Given the investment horizon of 90 days Spero Therapeutics is expected to generate 0.72 times more return on investment than Scpharmaceuticals. However, Spero Therapeutics is 1.38 times less risky than Scpharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.25 per unit of risk. If you would invest  129.00  in Spero Therapeutics on August 27, 2024 and sell it today you would lose (13.00) from holding Spero Therapeutics or give up 10.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Spero Therapeutics  vs.  Scpharmaceuticals

 Performance 
       Timeline  
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Spero Therapeutics and Scpharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spero Therapeutics and Scpharmaceuticals

The main advantage of trading using opposite Spero Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.
The idea behind Spero Therapeutics and Scpharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios